| Product NDC: | 0023-3615 |
| Proprietary Name: | ZYMAXID |
| Non Proprietary Name: | gatifloxacin |
| Active Ingredient(s): | 5 mg/mL & nbsp; gatifloxacin |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0023-3615 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022548 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100519 |
| Package NDC: | 0023-3615-25 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (0023-3615-25) > 2.5 mL in 1 BOTTLE, DROPPER |
| NDC Code | 0023-3615-25 |
| Proprietary Name | ZYMAXID |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (0023-3615-25) > 2.5 mL in 1 BOTTLE, DROPPER |
| Product NDC | 0023-3615 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | gatifloxacin |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 20100519 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | GATIFLOXACIN |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |